{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:45:18Z","timestamp":1792424718603,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-022-04188-9","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T13:03:02Z","timestamp":1668171782000},"page":"2901-2910","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Systematic review on oncologic outcomes on adjuvant endovesical treatment for non-muscle invasive bladder cancer in patients with solid organ transplant"],"prefix":"10.1007","volume":"40","author":[{"given":"Matthieu","family":"Simonet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Dominguez Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Territo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Prudhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia","family":"Andras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vital","family":"Hevia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6428-0273","authenticated-orcid":false,"given":"Romain","family":"Boissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the Young Academic Urologist (YAU) E. A. U. Group of Renal Transplantation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"issue":"1","key":"4188_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96\u2013108","journal-title":"Eur Urol"},{"key":"4188_CR2","unstructured":"Professionals SO (2020) EAU guidelines: non-muscle-invasive bladder cancer [Internet]. Uroweb. https:\/\/uroweb.org\/guideline\/non-muscle-invasive-bladder-cancer\/. Accessed 05 Apr 2020"},{"issue":"17","key":"4188_CR3","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2011.1592","volume":"306","author":"EA Engels","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF, Kasiske BL, Israni AK, Snyder JJ et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306(17):1891","journal-title":"JAMA"},{"issue":"8","key":"4188_CR4","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/ijc.24439","volume":"125","author":"CM Vajdic","year":"2009","unstructured":"Vajdic CM, van Leeuwen MT (2009) Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 125(8):1747\u20131754","journal-title":"Int J Cancer"},{"issue":"12","key":"4188_CR5","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1097\/00007890-199506270-00011","volume":"59","author":"SBM Gaya","year":"1995","unstructured":"Gaya SBM, Rees AJ, Lechler RI, Williams G, Mason PD (1995) Malignant disease in patients with long-term renal transplants. Transplantation 59(12):1705\u20131709","journal-title":"Transplantation"},{"issue":"9","key":"4188_CR6","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1097\/TP.0b013e3181a238f6","volume":"87","author":"Y Miao","year":"2009","unstructured":"Miao Y, Everly JJ, Gross TG, Tevar AD, First MR, Alloway RR et al (2009) De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation 87(9):1347\u20131359","journal-title":"Transplantation"},{"issue":"4","key":"4188_CR7","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.juro.2009.06.043","volume":"182","author":"B Ehdaie","year":"2009","unstructured":"Ehdaie B, Stukenborg GJ, Theodorescu D (2009) Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer. J Urol 182(4):1482\u20131487","journal-title":"J Urol"},{"issue":"88","key":"4188_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.urology.2015.10.031","volume":"1","author":"PU Ardelt","year":"2016","unstructured":"Ardelt PU, Rieken M, Ebbing J, Bonkat G, Vlajnic T, Bubendorf L et al (2016) Urothelial cancer in renal transplant recipients: incidence, risk factors, and oncological outcome. Urology 1(88):104\u2013110","journal-title":"Urology"},{"issue":"4","key":"4188_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.urology.2012.11.035","volume":"81","author":"D Prabharasuth","year":"2013","unstructured":"Prabharasuth D, Moses KA, Bernstein M, Dalbagni G, Herr HW (2013) Management of bladder cancer after renal transplantation. Urology 81(4):813\u2013819","journal-title":"Urology"},{"issue":"7","key":"4188_CR10","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/bjc.2014.44","volume":"110","author":"L Yan","year":"2014","unstructured":"Yan L, Chen P, Chen EZ, Gu A, Jiang ZY (2014) Risk of bladder cancer in renal transplant recipients: a meta-analysis. Br J Cancer 110(7):1871\u20131877","journal-title":"Br J Cancer"},{"issue":"6","key":"4188_CR11","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1097\/TP.0000000000001260","volume":"101","author":"S Liu","year":"2017","unstructured":"Liu S, Chaudhry MR, Berrebi AA, Papadimitriou JC, Drachenberg CB, Haririan A et al (2017) Polyomavirus replication and smoking are independent risk factors for bladder cancer after renal transplantation. Transplantation 101(6):1488\u20131494","journal-title":"Transplantation"},{"issue":"4","key":"4188_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jmv.1890410408","volume":"41","author":"T Shinohara","year":"1993","unstructured":"Shinohara T, Matsuda M, Cheng SH, Marshall J, Fujita M, Nagashima K (1993) BK virus infection of the human urinary tract. J Med Virol 41(4):301\u2013305","journal-title":"J Med Virol"},{"issue":"3","key":"4188_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/00313020902756303","volume":"41","author":"E Husain","year":"2009","unstructured":"Husain E, Prowse DM, Ktori E, Shaikh T, Yaqoob M, Junaid I et al (2009) Human papillomavirus is detected in transitional cell carcinoma arising in renal transplant recipients. Pathology 41(3):245\u2013247","journal-title":"Pathology"},{"issue":"2","key":"4188_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187\u2013196","journal-title":"Ann Surg"},{"issue":"4","key":"4188_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.euf.2017.02.014","volume":"4","author":"D Mitropoulos","year":"2018","unstructured":"Mitropoulos D, Artibani W, Biyani CS, Bjerggaard Jensen J, Roupr\u00eat M, Truss M (2018) Validation of the Clavien-Dindo grading system in urology by the european association of urology guidelines ad Hoc panel. Eur Urol Focus 4(4):608\u2013613","journal-title":"Eur Urol Focus"},{"issue":"2","key":"4188_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.acuro.2014.05.002","volume":"39","author":"O Rodr\u00edguez Faba","year":"2015","unstructured":"Rodr\u00edguez Faba O, Breda A, Gausa L, Palou J, Villavicencio H (2015) Tumores urol\u00f3gicos de novo en pacientes trasplantados renales. Actas Urol Esp 39(2):122\u2013127","journal-title":"Actas Urol Esp"},{"key":"4188_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2007.07210.x","author":"MM Kamal","year":"2007","unstructured":"Kamal MM, Soliman SM, Shokeir AA, Abol-Enein H, Ghoneim MA (2007) Bladder carcinoma among live-donor renal transplant recipients: a single-centre experience and a review of the literature. BJU Int. https:\/\/doi.org\/10.1111\/j.1464-410X.2007.07210.x","journal-title":"BJU Int"},{"issue":"10","key":"4188_CR18","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1016\/j.transproceed.2014.06.075","volume":"46","author":"S Medani","year":"2014","unstructured":"Medani S, O\u2019Kelly P, O\u2019Brien KM, Mohan P, Magee C, Conlon P (2014) Bladder cancer in renal allograft recipients: risk factors and outcomes. Transplant Proc 46(10):3466\u20133473","journal-title":"Transplant Proc"},{"issue":"3","key":"4188_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11255-011-9907-z","volume":"43","author":"J Cox","year":"2011","unstructured":"Cox J, Colli JL (2011) Urothelial cancers after renal transplantation. Int Urol Nephrol 43(3):681\u2013686","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"4188_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000481917","volume":"100","author":"A Palazzetti","year":"2018","unstructured":"Palazzetti A, Bosio A, Dalmasso E, Destefanis P, Fop F, Pisano F et al (2018) De Novo bladder urothelial neoplasm in renal transplant recipients: a retrospective, multicentered study. Urol Int 100(2):185\u2013192","journal-title":"Urol Int"},{"issue":"7\u20138","key":"4188_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00508-013-0343-1","volume":"125","author":"N Swietek","year":"2013","unstructured":"Swietek N, Waldert M, Susani M, Schatzl G, Klatte T (2013) Intravesical bacillus Calmette-Gu\u00e9rin instillation therapy for non-muscle-invasive bladder cancer following solid organ transplantation. Wien Klin Wochenschr 125(7\u20138):189\u2013195","journal-title":"Wien Klin Wochenschr"},{"issue":"12","key":"4188_CR22","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s00345-015-1554-z","volume":"33","author":"IA Ederer","year":"2015","unstructured":"Ederer IA, Lucca I, Hofbauer SL, Haidinger M, Haitel A, Susani M et al (2015) Histopathology and prognosis of de novo bladder tumors following solid organ transplantation. World J Urol 33(12):2087\u20132093","journal-title":"World J Urol"},{"issue":"2","key":"4188_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/tri.12484","volume":"28","author":"T Roumegu\u00e8re","year":"2015","unstructured":"Roumegu\u00e8re T, Broeders N, Jayaswal A, Rorive S, Quackels T, Pozdzik A et al (2015) Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy. Transpl Int 28(2):199\u2013205","journal-title":"Transpl Int"},{"issue":"6","key":"4188_CR24","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1464-410X.2012.11778.x","volume":"111","author":"HW Herr","year":"2013","unstructured":"Herr HW, Dalbagni G (2013) Intravesical bacille Calmette-Gu\u00e9rin (BCG) in immunologically compromised patients with bladder cancer: Intravesical BCG in immunologically compromised patients. BJU Int 111(6):984\u2013987","journal-title":"BJU Int"},{"issue":"2 Pt 2","key":"4188_CR25","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1111\/j.1464-410X.2011.10777.x","volume":"110","author":"A Rogers","year":"2012","unstructured":"Rogers A, Ng JK, Glendinning J, Rix D (2012) The management of transitional cell carcinoma (TCC) in a European regional renal transplant population. BJU Int 110(2 Pt 2):E34\u2013E40","journal-title":"BJU Int"},{"issue":"6","key":"4188_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1034\/j.1399-0012.2002.01152.x","volume":"16","author":"HB Wang","year":"2002","unstructured":"Wang HB, Hsieh HH, Chen YT, Chiang CY, Cheng YT (2002) The outcome of post-transplant transitional cell carcinoma in 10 renal transplant recipients. Clin Transplant 16(6):410\u2013413","journal-title":"Clin Transplant"},{"issue":"1","key":"4188_CR27","first-page":"32","volume":"16","author":"Y Neuzillet","year":"2006","unstructured":"Neuzillet Y, Davin JL, Lechevallier E (2006) Intravesical BCG instillations for the treatment of superficial bladder tumours in renal transplant recipients. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol 16(1):32\u201335","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"issue":"3\u20134","key":"4188_CR28","first-page":"477","volume":"38","author":"NN Dhanani","year":"2006","unstructured":"Dhanani NN, Kamat AM (2006) Treatment of bladder cancer in cardiac transplant patients. Int Urol Nephrol 38(3\u20134):477\u2013479","journal-title":"Int Urol Nephrol"},{"issue":"10","key":"4188_CR29","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1097\/01.TP.0000090748.32764.0F","volume":"76","author":"J Palou","year":"2003","unstructured":"Palou J, Angerri O, Segarra J, Caparr\u00f3s J, Guirado L, Diaz JM et al (2003) Intravesical bacillus calmette-gue\u00c8rin for the treatment of superficial bladder cancer in renal transplant patients. Transplantation 76(10):1514\u20131516","journal-title":"Transplantation"},{"issue":"2","key":"4188_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.eururo.2015.02.040","volume":"68","author":"L Mart\u00ednez-Pi\u00f1eiro","year":"2015","unstructured":"Mart\u00ednez-Pi\u00f1eiro L, Portillo JA, Fern\u00e1ndez JM, Zabala JA, Cadierno I, Moyano JL et al (2015) Maintenance therapy with 3-monthly Bacillus Calmette-Gu\u00e9rin for 3 years is not superior to standard induction therapy in high-risk non-muscle-invasive urothelial bladder carcinoma: final results of randomised CUETO study 98013. Eur Urol 68(2):256\u2013262","journal-title":"Eur Urol"},{"key":"4188_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/CMAR.S185796","volume":"11","author":"J Yu","year":"2018","unstructured":"Yu J, Lee CU, Kang M, Jeon HG, Jeong BC, Seo SI et al (2018) Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients. Cancer Manag Res 11:157\u2013166","journal-title":"Cancer Manag Res"},{"key":"4188_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/256985","volume":"2011","author":"JJ Tomaszewski","year":"2011","unstructured":"Tomaszewski JJ, Larson JA, Smaldone MC, Hayn MH, Jackman SV (2011) Management of bladder cancer following solid organ transplantation. Adv Urol 2011:1\u20137","journal-title":"Adv Urol"},{"issue":"1","key":"4188_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.urology.2009.06.106","volume":"75","author":"H Elkentaoui","year":"2010","unstructured":"Elkentaoui H, Robert G, Pasticier G, Bernhard JC, Couzi L, Merville P et al (2010) Therapeutic management of De Novo urological malignancy in renal transplant recipients: the experience of the french department of urology and kidney transplantation from Bordeaux. Urology 75(1):126\u2013132","journal-title":"Urology"},{"key":"4188_CR34","first-page":"395","volume":"4","author":"M Zhou","year":"2006","unstructured":"Zhou M, Zhu Y, Wang L, Wang Y, Fu S, Min Z (2006) Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases. Clin Transpl 4:395\u2013398","journal-title":"Clin Transpl"},{"issue":"13","key":"4188_CR35","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.purol.2008.08.002","volume":"18","author":"X Tillou","year":"2008","unstructured":"Tillou X, Raynal G, Limani K, Saint F, Petit J (2008) Carcinome in situ v\u00e9sical et ur\u00e9tral chez un patient transplant\u00e9 r\u00e9nal\u202f: \u00e9chec de la BCG th\u00e9rapie. Prog En Urol 18(13):1097\u20131099","journal-title":"Prog En Urol"},{"issue":"2","key":"4188_CR36","first-page":"166","volume":"14","author":"WKB Ranasinghe","year":"2016","unstructured":"Ranasinghe WKB, Suh N, Hughes PD (2016) Survival outcomes in renal transplant recipients with renal cell carcinoma or transitional cell carcinoma from the ANZDATA database. Exp Clin Transpl 14(2):166\u2013171","journal-title":"Exp Clin Transpl"},{"issue":"3","key":"4188_CR37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/MOU.0000000000000749","volume":"30","author":"B Pradere","year":"2020","unstructured":"Pradere B, Schuettfort V, Mori K, Quhal F, Aydh A, Sari MR (2020) Management of de-novo urothelial carcinoma in transplanted patients. Curr Opin Urol 30(3):467\u2013474","journal-title":"Curr Opin Urol"},{"issue":"2","key":"4188_CR38","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.eururo.2006.11.017","volume":"52","author":"PMJ Moonen","year":"2007","unstructured":"Moonen PMJ, Bakkers JMJE, Kiemeney LALM, Schalken JA, Melchers WJG, Witjes JA (2007) Human Papilloma Virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol 52(2):464\u2013469","journal-title":"Eur Urol"},{"issue":"5","key":"4188_CR39","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.transproceed.2011.03.053","volume":"43","author":"J Xiao","year":"2011","unstructured":"Xiao J, Zhu X, Hao GY, Zhu YC, Ma LL, Zhang YH et al (2011) Association between urothelial carcinoma after renal transplantation and infection by human papillomavirus types 16 and 18. Transplant Proc 43(5):1638\u20131640","journal-title":"Transplant Proc"},{"issue":"5","key":"4188_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12931","volume":"20","author":"J Ziegler","year":"2018","unstructured":"Ziegler J, Ho J, Gibson IW, Nayak JG, Stein M, Walkty A et al (2018) Disseminated Mycobacterium bovis infection post-kidney transplant following remote intravesical BCG therapy for bladder cancer. Transpl Infect Dis 20(5):e12931","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"4188_CR41","first-page":"711","volume":"36","author":"F Caravaca-Font\u00e1n","year":"2016","unstructured":"Caravaca-Font\u00e1n F, Cano Meg\u00edas M, S\u00e1nchez-Conde M, El\u00edas Trivi\u00f1o S, Fern\u00e1ndez-Rodr\u00edguez A, Lia\u00f1o F (2016) Subacute interstitial pneumonitis due to Mycobacterium bovis after intravesical bacillus Calmette-Gu\u00e9rin instillation in a renal transplant patient. Nefrol Engl Ed 36(6):711\u2013713","journal-title":"Nefrol Engl Ed"},{"issue":"5","key":"4188_CR42","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.transproceed.2018.02.086","volume":"50","author":"H Antunes","year":"2018","unstructured":"Antunes H, Tavares-da-Silva E, Oliveira R, Carvalho J, Parada B, Bastos C et al (2018) De Novo urologic malignancies in renal transplant recipients. Transpl Proc 50(5):1348\u20131354","journal-title":"Transpl Proc"},{"issue":"19","key":"4188_CR43","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs M (2020) Bladder cancer: a review. JAMA 324(19):1980","journal-title":"JAMA"},{"issue":"2","key":"4188_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW (1976) Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116(2):180\u2013183","journal-title":"J Urol"},{"issue":"5","key":"4188_CR45","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.eururo.2020.04.066","volume":"78","author":"MO Grimm","year":"2020","unstructured":"Grimm MO, van der Heijden AG, Colombel M, Muilwijk T, Mart\u00ednez-Pi\u00f1eiro L, Babjuk MM et al (2020) Treatment of high-grade non-muscle-invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations: results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial \u201cNIMBUS.\u201d Eur Urol 78(5):690\u2013698","journal-title":"Eur Urol"},{"issue":"4","key":"4188_CR46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/02656736.2016.1155760","volume":"32","author":"EIML Liem","year":"2016","unstructured":"Liem EIML, Crezee H, de la Rosette JJ, de Reijke TM (2016) Chemohyperthermia in non-muscle-invasive bladder cancer: an overview of the literature and recommendations. Int J Hyperth 32(4):363\u2013373","journal-title":"Int J Hyperth"},{"issue":"1","key":"4188_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ucl.2019.09.008","volume":"47","author":"WP Tan","year":"2020","unstructured":"Tan WP, Longo T, Inman BA (2020) Heated intravesical chemotherapy: biology and clinical utility. Urol Clin N Am 47(1):55\u201372","journal-title":"Urol Clin N Am"},{"issue":"6","key":"4188_CR48","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.eururo.2016.01.006","volume":"69","author":"TJH Arends","year":"2016","unstructured":"Arends TJH, Nativ O, Maffezzini M, de Cobelli O, Canepa G, Verweij F et al (2016) Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus Bacillus Calmette-Gu\u00e9rin for adjuvant treatment of patients with intermediate- and high-risk non\u2013muscle-invasive bladder cancer. Eur Urol 69(6):1046\u20131052","journal-title":"Eur Urol"},{"issue":"23","key":"4188_CR49","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/JCO.2003.01.089","volume":"21","author":"R Colombo","year":"2003","unstructured":"Colombo R, Da Pozzo LF, Salonia A, Rigatti P, Leib Z, Baniel J et al (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21(23):4270\u20134276","journal-title":"J Clin Oncol"},{"issue":"1","key":"4188_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11934-020-0954-9","volume":"21","author":"R Boissier","year":"2020","unstructured":"Boissier R, Delaporte V, Legris T, Moal V, Lechevallier E (2020) Pelvic surgery in the transplant recipient: important considerations for the non-transplant surgeon. Curr Urol Rep 21(1):2","journal-title":"Curr Urol Rep"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-04188-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-022-04188-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-04188-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T22:11:30Z","timestamp":1669846290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-022-04188-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4188"],"URL":"https:\/\/doi.org\/10.1007\/s00345-022-04188-9","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"10 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment\/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}